Maegdefessel L - Search Results

1

Mast cells participate in smooth muscle cell reprogramming and atherosclerotic plaque calcification.

Skenteris NT, Hemme E, Delfos L, Karadimou G, Karlöf E, Lengquist M, Kronqvist M, Zhang X, Maegdefessel L, Schurgers LJ, Arnardottir H, Biessen EAL, Bot I, Matic L. Skenteris NT, et al. Among authors: maegdefessel l. Vascul Pharmacol. 2023 Jun;150:107167. doi: 10.1016/j.vph.2023.107167. Epub 2023 Mar 21. Vascul Pharmacol. 2023. PMID: 36958707 Free article.

2

Erratum: miR-24 limits aortic vascular inflammation and murine abdominal aneurysm development.

Maegdefessel L, Spin JM, Raaz U, Eken SM, Toh R, Azuma J, Adam M, Nakagami F, Heymann HM, Chernogubova E, Jin H, Roy J, Hultgren R, Caidahl K, Schrepfer S, Hamsten A, Eriksson P, McConnell MV, Dalman RL, Tsao PS. Maegdefessel L, et al. Nat Commun. 2015 Feb 26;6:6506. doi: 10.1038/ncomms7506. Nat Commun. 2015. PMID: 25716653 Free PMC article. No abstract available.

3

Comparison of outcome in 1809 patients treated with drug-eluting stents or bare-metal stents in a real-world setting.

Vogt A, Schoelmerich A, Pollner F, Schlitt M, Raaz U, Maegdefessel L, Reindl I, Buerke M, Werdan K, Schlitt A. Vogt A, et al. Among authors: maegdefessel l. Vasc Health Risk Manag. 2011;7:693-9. doi: 10.2147/VHRM.S24370. Epub 2011 Nov 22. Vasc Health Risk Manag. 2011. PMID: 22174579 Free PMC article.

4

Efficacy of enoxaparin, certoparin and dalteparin in preventing cardiac catheter thrombosis: an in vitro approach.

Raaz U, Buerke M, Busshardt M, Maegdefessel L, Plehn A, Hauroeder B, Werdan K, Schlitt A. Raaz U, et al. Among authors: maegdefessel l. J Thromb Thrombolysis. 2010 Apr;29(3):265-70. doi: 10.1007/s11239-009-0355-x. J Thromb Thrombolysis. 2010. PMID: 19517216

5

In vitro comparison of dabigatran, unfractionated heparin, and low-molecular-weight heparin in preventing thrombus formation on mechanical heart valves.

Maegdefessel L, Linde T, Krapiec F, Hamilton K, Steinseifer U, van Ryn J, Raaz U, Buerke M, Werdan K, Schlitt A. Maegdefessel L, et al. Thromb Res. 2010 Sep;126(3):e196-200. doi: 10.1016/j.thromres.2010.06.011. Epub 2010 Jul 24. Thromb Res. 2010. PMID: 20659761

6

Serum phospholipid transfer protein activity after a high fat meal in patients with insulin-treated type 2 diabetes.

Schlitt A, Schwaab B, Fingscheidt K, Lackner KJ, Heine GH, Vogt A, Buerke M, Maegdefessel L, Raaz U, Werdan K, Jiang XC. Schlitt A, et al. Among authors: maegdefessel l. Lipids. 2010 Feb;45(2):129-35. doi: 10.1007/s11745-010-3384-5. Epub 2010 Jan 27. Lipids. 2010. PMID: 20108050

7

Argatroban and bivalirudin compared to unfractionated heparin in preventing thrombus formation on mechanical heart valves. Results of an in-vitro study.

Maegdefessel L, Linde T, Michel T, Hamilton K, Steinseifer U, Friedrich I, Schubert S, Hauroeder B, Raaz U, Buerke M, Werdan K, Schlitt A. Maegdefessel L, et al. Thromb Haemost. 2009 Jun;101(6):1163-9. Thromb Haemost. 2009. PMID: 19492162

8

Transcriptional profiling and network analysis of the murine angiotensin II-induced abdominal aortic aneurysm.

Spin JM, Hsu M, Azuma J, Tedesco MM, Deng A, Dyer JS, Maegdefessel L, Dalman RL, Tsao PS. Spin JM, et al. Among authors: maegdefessel l. Physiol Genomics. 2011 Sep 8;43(17):993-1003. doi: 10.1152/physiolgenomics.00044.2011. Epub 2011 Jun 28. Physiol Genomics. 2011. PMID: 21712436 Free PMC article.

9

Comparison of unfractionated heparin, low-molecular-weight heparin, low-dose and high-dose rivaroxaban in preventing thrombus formation on mechanical heart valves: results of an in vitro study.

Kaeberich A, Reindl I, Raaz U, Maegdefessel L, Vogt A, Linde T, Steinseifer U, Perzborn E, Hauroeder B, Buerke M, Werdan K, Schlitt A. Kaeberich A, et al. Among authors: maegdefessel l. J Thromb Thrombolysis. 2011 Nov;32(4):417-25. doi: 10.1007/s11239-011-0621-6. J Thromb Thrombolysis. 2011. PMID: 21773837

10

Patients with insulin-dependent diabetes or coronary heart disease following rehabilitation express serum fractalkine levels similar to those in healthy control subjects.

Maegdefessel L, Schlitt A, Pippig S, Schwaab B, Fingscheidt K, Raaz U, Buerke M, Loppnow H. Maegdefessel L, et al. Vasc Health Risk Manag. 2009;5:849-57. doi: 10.2147/vhrm.s6829. Epub 2009 Oct 12. Vasc Health Risk Manag. 2009. PMID: 19851523 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

175 results

Search Page